The product of trunk muscle area and density on the CT image is a good indicator of energy expenditure in patients with or at risk for COPD.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
15 Jan 2021
Historique:
received: 09 07 2020
accepted: 10 01 2021
entrez: 16 1 2021
pubmed: 17 1 2021
medline: 30 1 2021
Statut: epublish

Résumé

Physical inactivity due to cachexia and muscle wasting is well recognized as a sign of poor prognosis in chronic obstructive pulmonary disease (COPD). However, there have been no reports on the relationship between trunk muscle measurements and energy expenditure parameters, such as the total energy expenditure (TEE) and physical activity level (PAL), in COPD. In this study, we investigated the associations of computed tomography (CT)-derived muscle area and density measurements with clinical parameters, including TEE and PAL, in patients with or at risk for COPD, and examined whether these muscle measurements serve as an indicator of TEE and PAL. The study population consisted of 36 male patients with (n = 28, stage 1-4) and at risk for (n = 8) COPD aged over 50 years. TEE was measured by the doubly labeled water method, and PAL was calculated as the TEE/basal metabolic rate estimated by the indirect method. The cross-sectional areas and densities of the pectoralis muscles, rectus abdominis muscles, and erector spinae muscles were measured. We evaluated the relationship between these muscle measurements and clinical outcomes, including body composition, lung function, muscle strength, TEE, and PAL. All the muscle areas were significantly associated with TEE, severity of emphysema, and body composition indices such as body mass index, fat-free mass, and trunk muscle mass. All trunk muscle densities were correlated with PAL. The product of the rectus abdominis muscle area and density showed the highest association with TEE (r = 0.732) and PAL (r = 0.578). Several trunk muscle measurements showed significant correlations with maximal inspiratory and expiratory pressures, indicating their roles in respiration. CT-derived measurements for trunk muscles are helpful in evaluating physical status and function in patients with or at risk for COPD. Particularly, trunk muscle evaluation may be a useful marker reflecting TEE and PAL.

Sections du résumé

BACKGROUND BACKGROUND
Physical inactivity due to cachexia and muscle wasting is well recognized as a sign of poor prognosis in chronic obstructive pulmonary disease (COPD). However, there have been no reports on the relationship between trunk muscle measurements and energy expenditure parameters, such as the total energy expenditure (TEE) and physical activity level (PAL), in COPD. In this study, we investigated the associations of computed tomography (CT)-derived muscle area and density measurements with clinical parameters, including TEE and PAL, in patients with or at risk for COPD, and examined whether these muscle measurements serve as an indicator of TEE and PAL.
METHODS METHODS
The study population consisted of 36 male patients with (n = 28, stage 1-4) and at risk for (n = 8) COPD aged over 50 years. TEE was measured by the doubly labeled water method, and PAL was calculated as the TEE/basal metabolic rate estimated by the indirect method. The cross-sectional areas and densities of the pectoralis muscles, rectus abdominis muscles, and erector spinae muscles were measured. We evaluated the relationship between these muscle measurements and clinical outcomes, including body composition, lung function, muscle strength, TEE, and PAL.
RESULTS RESULTS
All the muscle areas were significantly associated with TEE, severity of emphysema, and body composition indices such as body mass index, fat-free mass, and trunk muscle mass. All trunk muscle densities were correlated with PAL. The product of the rectus abdominis muscle area and density showed the highest association with TEE (r = 0.732) and PAL (r = 0.578). Several trunk muscle measurements showed significant correlations with maximal inspiratory and expiratory pressures, indicating their roles in respiration.
CONCLUSIONS CONCLUSIONS
CT-derived measurements for trunk muscles are helpful in evaluating physical status and function in patients with or at risk for COPD. Particularly, trunk muscle evaluation may be a useful marker reflecting TEE and PAL.

Identifiants

pubmed: 33451329
doi: 10.1186/s12931-021-01621-2
pii: 10.1186/s12931-021-01621-2
pmc: PMC7811265
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

18

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : JP17ek0210045 and JP20ek0210112

Références

Am J Clin Nutr. 2006 Apr;83(4):735-43
pubmed: 16600922
Int J Chron Obstruct Pulmon Dis. 2015 Jun 15;10:1129-37
pubmed: 26109854
Respir Med. 2010 Mar;104(3):378-88
pubmed: 19932014
Am J Respir Crit Care Med. 1997 Feb;155(2):549-54
pubmed: 9032193
Atherosclerosis. 2008 Oct;200(2):359-67
pubmed: 18243217
Ann Am Thorac Soc. 2016 Mar;13(3):334-41
pubmed: 26700501
Am J Phys Med Rehabil. 1999 Sep-Oct;78(5):464-9
pubmed: 10493457
Chest. 2011 Aug;140(2):331-342
pubmed: 21273294
Eur Respir J. 1997 Jul;10(7):1576-80
pubmed: 9230250
Am J Respir Crit Care Med. 1998 Aug;158(2):629-34
pubmed: 9700144
Respir Med. 2005 Aug;99(8):1004-9
pubmed: 15950141
Ann Am Thorac Soc. 2014 Mar;11(3):326-34
pubmed: 24558953
Br J Nutr. 1995 Apr;73(4):571-81
pubmed: 7794872
Respir Med. 2000 Sep;94(9):859-67
pubmed: 11001077
Am J Respir Crit Care Med. 2002 Sep 15;166(6):809-13
pubmed: 12231489
Proc Am Thorac Soc. 2008 May 1;5(4):519-23
pubmed: 18453365
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
Eur Respir J. 2014 Dec;44(6):1504-20
pubmed: 25234804
Tuberc Respir Dis (Seoul). 2017 Jul;80(3):226-229
pubmed: 28747954
Am Rev Respir Dis. 1991 Jun;143(6):1248-52
pubmed: 2048807
Lancet. 2012 Apr 7;379(9823):1341-51
pubmed: 22314182
Respir Med. 2011 Jun;105(6):922-9
pubmed: 21276720
Chronic Obstr Pulm Dis. 2019 Oct 23;6(4):
pubmed: 31999904
Clin Physiol. 1992 Nov;12(6):629-40
pubmed: 1424481
Respir Res. 2019 Oct 21;20(1):226
pubmed: 31638996
BMJ Open Diabetes Res Care. 2019 Mar 25;7(1):e000648
pubmed: 31114702
J Physiol. 1949 Aug;109(1-2):1-9
pubmed: 15394301
Phys Med Biol. 2006 Jul 7;51(13):R203-28
pubmed: 16790904
Gerontology. 2009;55(2):217-23
pubmed: 19060453
Respir Investig. 2014 Jul;52(4):242-50
pubmed: 24998371
Arthritis Care Res (Hoboken). 2015 Jul;67(7):1031-40
pubmed: 25623494
Ann N Y Acad Sci. 2000 May;904:18-24
pubmed: 10865705
Physiol Rep. 2013 Nov;1(6):e00150
pubmed: 24400152
Respir Res. 2018 Apr 10;19(1):62
pubmed: 29636050
Lancet. 2006 May 27;367(9524):1747-57
pubmed: 16731270
Respir Med. 2006 Mar;100(3):561-7
pubmed: 16019198
Clin Nutr. 2003 Apr;22(2):159-65
pubmed: 12706133
Eur Respir J. 2013 Nov;42(5):1205-15
pubmed: 23397303
PLoS One. 2017 Jul 10;12(7):e0180928
pubmed: 28700654

Auteurs

Toru Shirahata (T)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan. t.shirahata+doctor@gmail.com.

Hideaki Sato (H)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.

Sanehiro Yogi (S)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.

Kaiji Inoue (K)

Department of Radiology, Saitama Medical University, Saitama, Japan.

Mamoru Niitsu (M)

Department of Radiology, Saitama Medical University, Saitama, Japan.

Tomoe Akagami (T)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.

Machika Soma (M)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.

Tomohiko Mio (T)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.

Makoto Nagata (M)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.

Satoshi Nakae (S)

Department of Nutrition and Metabolism, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.
Graduate School of Engineering Science, Osaka University, Osaka, Japan.

Yuki Nishida (Y)

Department of Nutrition and Metabolism, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.

Shigeho Tanaka (S)

Department of Nutrition and Metabolism, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan.
Faculty of Nutrition, Kagawa Nutrition University, Saitama, Japan.

Fuminori Katsukawa (F)

Sports Medicine Research Center, Keio University, Yokohama, Japan.

Hidetoshi Nakamura (H)

Department of Respiratory Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH